Thursday, November 14, 2013 9:24:30 PM
Berkowitz & Associates have preemptively thwarted robbing of F&F.
By making an offer to buy just the insurance part of F&F for $50B, Berkowitz & Associates have proved the existence of a significant value in F&F equity. This challenges the short-sellers and their allied politicians/experts/lobbyists who had been spreading misinformation about worthlessness of F&F equity and pursuing for winding down of F&F to loot F&F stakeholders including taxpayers.
The short-sellers were counting that they did not have to cover their short interest on F&F equity as their allied lawmakers/experts/lobbyists pursued for winding down of F&F. They had almost succeeded with President Obama chiming along and their top expert rising to head the Federal Reserve.
But, alas!, President Obama and Democrats realized that the 100% F&F Profit Sweep Agreement foisted by these short-sellers and their experts/lobbyists amounted to a massive transfer of wealth from borrowers to the Treasury amounting to an effective reduction in taxes of the wealthy. In addition, the winding down of F&F would impose an enormously high interest burden on the borrowers. The President and Democratic leaders had to make a U-turn as they saw huge F&F profits.
The offer of Berkowitz & Associates has preemptively thwarted robbing of F&F stakeholders by the short-sellers and their allied lawmakers/experts/lobbyists. It will galvanize President Obama and Treasury to muzzle any remaining murmur for F&F wind-down, then void the illegitimate Profit Sweep Agreement, and release F&F from Conservatorship. President Obama and Democrats will not agree to sell any part of F&F equity. They would rather have F&F facilitate private investment in GSE debt. This will effectively serve the goal of Berkowitz & Associates and financially destroy those who had schemed to rob F&F and their stakeholders (including taxpayers
http://finance.yahoo.com/mbview/threadview/?&bn=e0e2b58d-64fb-37a2-9273-29a5ce093d80&tid=1384406478024-1491510a-2a17-4407-bc29-8c7ec7b6cec2&tls=la%2Cd%2C3%2C3
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM